Jeffrey M Rowe insider trades: Zomedica (ZOM) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jeffrey reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 17, 2025 | ZOM | ↑ Buy | 1,439,005 | $0.07 | $96K | Jeffrey M. Rowe Living Trust | Mar 18, 2025 (1d) |
| Mar 25, 2015 | DPLO | ↓ Sell | 600,000 | $29.00 | $17.4M | Direct | Mar 27, 2015 (2d) |
| Oct 9, 2014 | DPLO | ↓ Sell | 208,333 | $13.00 | $2.7M | Rowe Family Trusts | Oct 10, 2014 (1d) |
| Oct 9, 2014 | DPLO | ↓ Sell | 208,333 | $13.00 | $2.7M | Direct | Oct 10, 2014 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Jeffrey M Rowe's insider trades
Jeffrey M Rowe is an insider at Zomedica (ZOM). Since Oct 9, 2014, Jeffrey has reported 1 open-market purchase worth $96K and 3 sales worth $22.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (6 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ZOM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.